期刊文献+

老年冠心病患者阿司匹林应用情况的临床分析 被引量:1

Investigation of Aspirin Use in Elderly Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的分析老年冠心病患者中阿司匹林临床应用现状及为新剂型研发提供参考依据。方法对2015年1月-2016年8月收治的400例老年冠心病患者的临床资料进行研究,根据患者阿司匹林服用情况,将上述患者分为三组,统计上述三组患者冠心病住院次数以及严重心血管事件的发生次数。结果 (1)观察组住院频次显著低于对照1组、对照2组,组间差异具有统计学意义(P<0.05)。(2)观察组心肌梗死几率、心脏猝死几率显著低于对照1组、对照2组,组间差异具有统计学意义(P<0.05)。结论在无绝对禁忌症情况下,老年冠心病病人应坚持服用阿司匹林。 Objective To analyze the clinical application of aspirin in elderly patients with coronary heart disease (CHD), and to provide reference for the development of new dosage forms. Methods The clinical data of 400 cases of elderly patients with coronary heart disease in our hospital in January 2015 -2016 year in August were studied retrospectively, according to the condition of patients taking aspirin, the patients were divided into three groups, the three groups were statistical coronary heart disease hospitalization and incidence of serious cardiovascular events frequently. Results The observation group hospitalization frequency was significantly lower than the control group 1, control group 2, the difference was statistically significant (P 〈 0. 05 ). The observation group risk of myocardial infarction, sudden cardiac death rate siguificantlyThan that of the control group 1, control group 2, the difference was statistically significant (P 〈 0. 05 ). Conclusions In the case of no absolute contraindication, elderly patients with coronary heart disease should take aspirin.
作者 王冰 WANG Bing(Emergency Department, Xuchang Central Hospital, Henan Province, 461000)
出处 《航空航天医学杂志》 2017年第5期517-518,共2页 Journal of Aerospace medicine
关键词 老年患者 冠心病 阿司匹林 elderly patients coronary heart disease aspirin
  • 相关文献

参考文献2

二级参考文献46

  • 1Gurbel PA,Antonino MJ,Tantry US. Recent developmentsin clopidogrel pharmacology and their relation to clinicaloutcomes [J]. Expert Opin Drug Metab Toxicol,2009,5(8):989-1004.
  • 2Pamuku B,Oflaz H,Nianci Y. A current problem inatherothrombotic diseases—aspirin resistance : definition mechanisms determination with laboratory tests and clin-ical implications [J]. Anadolu Kardiyol Derg20077(Suppl 2):20-26.
  • 3Gurbel PA Bliden KP,Hiatt BL,et al. Clopidogrel forcoronary stenting:response variabilitydrug resistance,and the effect of pretreatment platelet reactivity [J]. Cir-culation ,2003,107(23):2908-2913.
  • 4Tantry US,Bliden KP,Gurbel PA,et al. Resistance to an-tiplatelet drugs:current status and future research [J]. Ex-pert Opin Pharmacother,2005,6(12) :2027-2045.
  • 5Nguyen TA,Diodati JG,Pharand C. Resistance to clopi-dogrel :a review of the evidence [J]. J Am Coll Cardiol,2005 ,45(8):1157-1164.
  • 6Li C,Hirsh J,Sloane D,et al. Aspirin response variabilityafter major orthopedic surgery [J]. Thromb Res,2012,130(2):216-220.
  • 7Bonello L,Tantry US,Marcucci R,et al. Consensus andfuture directions on the definition of high on-treatmentplatelet reactivity to adenosine diphosphate[J]. J Am CollCardiol,2010,56(12):919-933.
  • 8Woo KS,Kim BR,Kim JE,et al. Determination of theprevalence of aspirin and clopidogrel resistances in pa-tients with coronary artery disease by using variousplatelet-function tests [J]. Korean J Lab Med,2010,30(5):460-468.
  • 9Born GV. Aggregation of blood platelets by adenosinediphosphate and its reversal[J]. Nature,1962,194:927-929.
  • 10Trenk D,Hochholzer W,Fromm MF,et al. CytochromeP450 2C19 681G>A polymorphism and high on-clopido-grel platelet reactivity associated with adverse 1 -yearclinical outcome of elective percutaneous coronary inter-vention with drug-eluting or bare-metal stents [J]. J AmColl Cardiol,2008,51(20):1925-1934.

共引文献22

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部